Market Value1,982,008,000
Total Holdings84
File Date2016-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
YMTX / Yumanity Therapeutics Inc
CELG / Celgene Corp.
QTNT / Quotient Ltd
NLTX / Neoleukin Therapeutics, Inc.
RGLS / Regulus Therapeutics Inc.
NKTR / Nektar Therapeutics
88165UAB5 / TetraLogic Pharmaceuticals Corporation Bond
CYAD / Celyad Oncology - ADR
SNDX / Syndax Pharmaceuticals, Inc.
ACRS / Aclaris Therapeutics, Inc.
ARDX / Ardelyx, Inc.
EGRX / Eagle Pharmaceuticals, Inc.
WVE / Wave Life Sciences Ltd.
ATRA / Atara Biotherapeutics, Inc.
US64052L1061 / Neos Therapeutics, Inc.
09074D103 / Biotie Therapies Corp.
AGEN / Agenus Inc.
AVEO / AVEO Pharmaceuticals Inc
PVCT / Provectus Biopharmaceuticals, Inc.
CRIS / Curis, Inc.
DERM / Journey Medical Corporation
NVAX / Novavax, Inc.
US62857M1053 / MyoKardia, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
MTEM / Molecular Templates, Inc.
KITE / Kite Pharma, Inc.
TSRO / TESARO, Inc.
NBIX / Neurocrine Biosciences, Inc.
CTMX / CytomX Therapeutics, Inc.
MCRB / Seres Therapeutics, Inc.
LPCN / Lipocine Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
COLL / Collegium Pharmaceutical, Inc.
IMDZ / Immune Design Corp.
APTO / Aptose Biosciences Inc.
IOVA / Iovance Biotherapeutics, Inc.
EPZM / Epizyme Inc
DVAX / Dynavax Technologies Corporation
US7170711045 / Pfenex Inc.
SRNE / Sorrento Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
XLRN / Acceleron Pharma Inc
REPH / Societal CDMO Inc
ALKS / Alkermes plc
AGTC / Applied Genetic Technologies Corp
EPRSQ / Epirus Biopharmaceuticals Inc
AGRX / Agile Therapeutics, Inc.
CLRB / Cellectar Biosciences, Inc.
HRTX / Heron Therapeutics, Inc.
SRRA / Sierra Oncology Inc
15117F112 / Cellectar Biosciences, Inc. Series A Warrants
NVRO / Nevro Corp.
PVCT / Provectus Biopharmaceuticals, Inc.
ZYNE / Zynerba Pharmaceuticals Inc
GLYC / GlycoMimetics, Inc.
VTAE / Vitae Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
NSTG / NanoString Technologies, Inc.
FOLD / Amicus Therapeutics, Inc.
VCYT / Veracyte, Inc.
DXCM / DexCom, Inc.
CFRX / ContraFect Corp
CHRS / Coherus Oncology, Inc.
FWP / Forward Pharma A/S - ADR
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
MGNX / MacroGenics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
RGNX / REGENXBIO Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
NERV / Minerva Neurosciences, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
RMTI / Rockwell Medical, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
HTGM / HTG Molecular Diagnostics Inc
IL0011177958 / Intec Pharma Ltd
GNVC / GenVec, Inc.
OMER / Omeros Corporation
PATI / Patriot Transportation Holding, Inc.
TPST / Tempest Therapeutics, Inc.
CBPO / China Biologic Products Holdings Inc
0PP / Portola Pharmaceuticals Inc